Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results

RENOVIS INC (RNVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/17/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2009 SC 13G/A RENAISSANCE TECHNOLOGIES LLC reports a 0% stake in RENOVIS, INC.
02/09/2009 SC 13G/A DIMENSIONAL FUND ADVISORS INC reports a 0% stake in RENOVIS INC
05/08/2008 4 PENHOET EDWARD (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 79,028 shares @ $0
Disposed/sold 11,111 options to buy @ $3.42, valued at $38k
Disposed/sold 44,444 options to buy @ $4.5, valued at $200k
05/07/2008 4 EVNIN ANTHONY B (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 5,678 shares @ $0
Disposed/sold 1,304,060 shares @ $0
Disposed/sold 22,222 options to buy @ $4.5, valued at $100k
Disposed/sold 11,111 options to buy @ $11.7, valued at $130k
Disposed/sold 11,111 options to buy @ $18.185, valued at $202.1k
Disposed/sold 11,111 options to buy @ $3.42, valued at $38k
05/07/2008 4 CROWELL NANCY M (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 11,111 options to buy @ $3.42, valued at $38k
Disposed/sold 4,444 options to buy @ $1.125, valued at $5k
Disposed/sold 22,222 options to buy @ $4.5, valued at $100k
05/07/2008 4 WALKER JOHN PETER (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 160,840 shares @ $0
Disposed/sold 4,444 options to buy @ $1.125, valued at $5k
Disposed/sold 22,222 options to buy @ $4.5, valued at $100k
Disposed/sold 11,111 options to buy @ $8.16, valued at $90.7k
Disposed/sold 22,222 options to buy @ $3.42, valued at $76k
05/07/2008 4 CARTER BRUCE L A (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 11,111 options to buy @ $3.42, valued at $38k
Disposed/sold 22,222 options to buy @ $6.8, valued at $151.1k
05/06/2008 4 GOODMAN COREY S (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 272,823 shares @ $0
Disposed/sold 285,395 shares @ $0
Disposed/sold 5,556 options to buy @ $1.125, valued at $6.3k
Disposed/sold 116,667 options to buy @ $1.35, valued at $157.5k
Disposed/sold 24,444 options to buy @ $1.125, valued at $27.5k
Disposed/sold 133,333 options to buy @ $4.5, valued at $600k
05/06/2008 4 Farrow Jeffrey S (V.P., Finance and CAO) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 62,286 shares @ $0
Disposed/sold 15,523 options to buy @ $5.4, valued at $83.8k
Disposed/sold 1,698 options to buy @ $5.4, valued at $9.2k
Disposed/sold 25,494 options to buy @ $2.62, valued at $66.8k
Disposed/sold 756 options to buy @ $2.62, valued at $2k
05/06/2008 4 KELLY MICHAEL GERALD (SVP, Research & Development) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 197,084 shares @ $0
Disposed/sold 27,777 options to buy @ $1.35, valued at $37.5k
Disposed/sold 38,888 options to buy @ $1.35, valued at $52.5k
Disposed/sold 47,777 options to buy @ $4.5, valued at $215k
Disposed/sold 100,000 options to buy @ $2.62, valued at $262k
05/06/2008 4 HEMBERGER JUDITH A (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 11,111 options to buy @ $3.42, valued at $38k
05/06/2008 4 FRIEDMAN JOHN H (Director) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 11,111 options to buy @ $3.42, valued at $38k
Disposed/sold 22,222 options to buy @ $4.5, valued at $100k
05/06/2008 4 Perry Marlene F (SVP, HR & Facilities) has filed a Form 4 on RENOVIS INC
Txns: Disposed/sold 105,957 shares @ $0
05/02/2008 8-K Quarterly results
05/01/2008 425 Form 425 - Prospectuses and communications, business combinations
05/01/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Renovis Stockholders Approve Acquisition by Evotec"
04/29/2008 SC 13G MMCAP International Inc. SPC reports a 10% stake in Renovis, Inc.
04/29/2008 4 MM ASSET MANAGEMENT INC. (10% Owner) has filed a Form 4 on RENOVIS INC
Txns: Bought 1,400 shares @ $2.25, valued at $3.2k
Bought 100 shares @ $2.27, valued at $227
Bought 100 shares @ $2.28, valued at $228
Bought 26,800 shares @ $2.3, valued at $61.6k
Bought 10,000 shares @ $2.28, valued at $22.8k
Sold 390,000 shares @ $2.24, valued at $873.6k
Sold 10,000 shares @ $2.23, valued at $22.3k
04/29/2008 4 MMCAP International Inc. SPC (10% Owner) has filed a Form 4 on RENOVIS INC
Txns: Bought 1,400 shares @ $2.25, valued at $3.2k
Bought 100 shares @ $2.27, valued at $227
Bought 100 shares @ $2.28, valued at $228
Bought 26,800 shares @ $2.3, valued at $61.6k
Bought 10,000 shares @ $2.28, valued at $22.8k
Sold 390,000 shares @ $2.24, valued at $873.6k
Sold 10,000 shares @ $2.23, valued at $22.3k
Bought 1,400 shares @ $2.25, valued at $3.2k
Bought 100 shares @ $2.27, valued at $227
Bought 100 shares @ $2.28, valued at $228
Bought 26,800 shares @ $2.3, valued at $61.6k
04/25/2008 425 Form 425 - Prospectuses and communications, business combinations
04/25/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "PROXY GOVERNANCE AND EGAN-JONES RECOMMEND RENOVIS SHAREHOLDERS VOTE FOR MERGER WITH EVOTEC"
04/22/2008 425 Form 425 - Prospectuses and communications, business combinations
04/22/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "GLASS LEWIS & CO. RECOMMENDS RENOVIS SHAREHOLDERS VOTE FOR MERGER WITH EVOTEC"
04/18/2008 425 Form 425 - Prospectuses and communications, business combinations
04/18/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "ISS/RISK METRICS RECOMMENDS RENOVIS SHAREHOLDERS VOTE FOR MERGER WITH EVOTEC"
04/16/2008 425 Form 425 - Prospectuses and communications, business combinations
04/03/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/03/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Renovis Announces Expiration of Hart-Scott-Rodino 30-Day Waiting Period; Merger with Evotec On Track to Close In Early May, 2008 South San Francisco, California - April 3, 2008 - Renovis, Inc. , a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired without the United States Federal Trade Commission requesting additional information with regard to the pending acquisition of Renovis by Evotec AG . The companies anticipate that the transaction, which remains subject to the approval of Renovis's stockholders and other customary closing conditions, will close in earl..."
03/28/2008 425 Form 425 - Prospectuses and communications, business combinations
03/28/2008 425 Form 425 - Prospectuses and communications, business combinations
03/26/2008 425 Form 425 - Prospectuses and communications, business combinations
03/26/2008 8-K Other Events
03/25/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy